Nunzia Pharmaceutical Company Insiders
| NUNZ Stock | USD 0 0.00 0.00% |
Nunzia Pharmaceutical employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 7 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Break down of Nunzia Pharmaceutical's management performance can provide insight into the company performance.
| Michael Mitsunaga Insider CFO and President |
| Sara Gonzales Insider CEO Director |
Nunzia |
Nunzia Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of (2702.3914) % which means that it has lost $2702.3914 on every $100 spent on assets. This is way below average. Nunzia Pharmaceutical's management efficiency ratios could be used to measure how well Nunzia Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Nunzia Pharmaceutical Workforce Comparison
Nunzia Pharmaceutical is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 30.0. Nunzia Pharmaceutical holds roughly 3.0 in number of employees claiming about 10% of equities under Drug Manufacturers—Specialty & Generic industry.
Nunzia Pharmaceutical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Nunzia Pharmaceutical Price Series Summation is a cross summation of Nunzia Pharmaceutical price series and its benchmark/peer.
Nunzia Pharmaceutical Notable Stakeholders
A Nunzia Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nunzia Pharmaceutical often face trade-offs trying to please all of them. Nunzia Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nunzia Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Mitsunaga | CFO and President | Profile | |
| Sara Gonzales | CEO Director | Profile | |
| Shujie Cui | Chief Officer | Profile |
About Nunzia Pharmaceutical Management Performance
The success or failure of an entity such as Nunzia Pharmaceutical often depends on how effective the management is. Nunzia Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nunzia management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nunzia management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California. Nunzia Pharmaceutical is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Nunzia Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nunzia Pharmaceutical. Check Nunzia Pharmaceutical's Beneish M Score to see the likelihood of Nunzia Pharmaceutical's management manipulating its earnings.
Nunzia Pharmaceutical Workforce Analysis
Traditionally, organizations such as Nunzia Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nunzia Pharmaceutical within its industry.Nunzia Pharmaceutical Manpower Efficiency
Return on Nunzia Pharmaceutical Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 3M | |
| Net Loss Per Executive | 3M |
Additional Tools for Nunzia Pink Sheet Analysis
When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.